BioNTech SE (BNTX)
92.72
+0.48
(+0.52%)
USD |
NASDAQ |
May 03, 16:00
94.00
+1.28
(+1.38%)
After-Hours: 20:00
BioNTech Total Liabilities (Quarterly): 3.051B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.051B |
September 30, 2023 | 2.477B |
June 30, 2023 | 2.520B |
March 31, 2023 | 1.978B |
December 31, 2022 | 3.457B |
September 30, 2022 | 4.221B |
June 30, 2022 | 4.518B |
March 31, 2022 | 4.899B |
December 31, 2021 | 4.458B |
September 30, 2021 | 6.404B |
Date | Value |
---|---|
June 30, 2021 | 4.363B |
March 31, 2021 | 1.975B |
December 31, 2020 | 1.165B |
September 30, 2020 | 612.35M |
June 30, 2020 | 417.83M |
March 31, 2020 | 313.32M |
December 31, 2019 | 340.71M |
September 30, 2019 | 352.30M |
June 30, 2019 | 384.17M |
December 31, 2018 | 441.53M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
313.32M
Minimum
Mar 2020
6.404B
Maximum
Sep 2021
2.521B
Average
2.477B
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
Pfizer Inc | 137.21B |
Moderna Inc | 3.912B |
Autolus Therapeutics PLC | 263.91M |
Novavax Inc | 2.514B |
BioVie Inc | 14.00M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 25.43B |
Shareholders Equity (Quarterly) | 22.38B |
Debt to Equity Ratio | 0.0108 |
Current Ratio | 9.431 |
Net Debt Paydown Yield | 0.02% |